Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar Ipad (32.94) Submitted: 9/22/2011 11:30:14 PM : Outperform Start Price: $35.07 LLY Score: -0.08

fundamentals look very goog

Featured Broker Partners


Advertisement